Medtide Inc. (HKG:3880)
Hong Kong · Delayed Price · Currency is HKD 22.66
+0.08 (0.35%)
Jul 31, 2026, 3:54 PM HKT
Medtide Market Cap
Medtide has a market cap or net worth of 3.19 billion as of July 31, 2026. Its market cap has decreased by -36.29% in one year.
Market Cap
3.19B
Enterprise Value
2.03B
Revenue
634.40M
Ranking
n/a
PE Ratio
12.43
Stock Price
22.66
ChartMarket Cap Chart
Since June 30, 2025, Medtide's market cap has decreased from 4.37B to 3.19B, a decrease of -26.88%. That is a compound annual growth rate of -25.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 3.19B | -26.12% |
| Dec 31, 2025 | 4.32B | -1.04% |
| Jun 30, 2025 | 4.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jacobio Pharmaceuticals Group | 3.78B |
| Mirxes Holding Company | 3.66B |
| Qyuns Therapeutics | 3.62B |
| Guangzhou Innogen Pharmaceutical Group | 3.38B |
| HJ Science | 3.13B |
| Jiangsu Recbio Technology | 3.10B |
| Shandong Boan Biotechnology | 2.92B |
| Beijing Luzhu Biotechnology | 2.79B |